Key Market Indicators
Belgian beta blocking medicine sales are set to hit $71.56 million by 2026. This figure is a slight decrease from the $86.13 million reported in 2021. On average, the market has fallen by 2.8% year on year since 2007. South Korea overtook Belgium in 2021 and came in at number one with sales of $86.13 million. Italy, Canada and Australia took second, third and fourth place respectively.
